Published: Mar 29, 2021
CAMBRIDGE, Mass. & MONTREAL (BUSINESS WIRE) Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that each of its Executive Vice President and Chief Financial Officer, Steve Forte and its Executive Vice President and Chief Medical Officer, Maria Koehler (collectively, the “Executives”), have established Automatic Securities Disposition Plans (“ASDPs”) in accordance with applicable United States and Canadian securities legislation, including U.S. Securities and Exchange Commission (“SEC”) rule 10b5-1 and the recommended practices set forth in the recently issued Canadian Securities Administrators’ Staff Notice 55-317 (“Staff Notice 55-317”) and the Company’s internal policies.
UniSA PhD student Kaitlin Scheer flanked by Chris Adam’s parents, Marty and Cherrie.
The family of a young man who lost his battle with brain cancer is financially supporting UniSA PhD candidate Kaitlin Scheer to help find a cure for the deadly disease.
Kaitlin has been awarded a $5000 Chris Adams Research Grant to develop a model which better predicts poor glioblastoma responders, allowing them to pursue different treatment options.
Chris Adams lost his battle in November 2015 after being diagnosed with a rare grade-three anaplastic astrocytoma brain tumour. His family is honouring his memory by supporting the Neurosurgical Research Foundation which funds vital research into brain cancer.
Published: Apr 01, 2021
Software integration is touted as the most important therapeutic advancements, likely to yield promising results
Fact.MR, Rockville MD: The glaucoma diagnostics market is anticipated to post substantial gains through 2021 and beyond, as ophthalmic clinics resume elective surgeries in the post-pandemic scenario. Long-term prospects are expected to remain underpinned by immense promises exhibited by virtue of technological integration to fast-track surgical procedures and reduction of patient trauma.
According to a study published in the National Center for Biotechnology Information, global prevalence of glaucoma for the population aged 40-80 years is over 3%, with primary open angle glaucoma prevalence being the highest in Africa (4.2%), while incidence of primary angle closure glaucoma is the highest in Asia, at 1.1%. It was further established that the total number of glaucoma patients would rise to 76 million by 2020, and further to 111.8 million by
WASHINGTON, D.C. Stagnant public funding for agricultural research is threatening the future vitality of U.S. food systems – posing risks to farmer productivity and profitability, the steady supply of
#JOBS: The “I’m just grateful to have a job” mentality predates the pandemic but the massive wave of unemployment definitely supercharged it. But let’s stop for a moment and really think about it. Is grateful the right word when it comes to unemployment?